Atrial Fibrillation Management and Outcomes
This cluster of papers focuses on the management, treatment, and risk assessment of atrial fibrillation (AF). It covers topics such as anticoagulant therapy, catheter ablation, stroke prevention, risk stratification, and guidelines for managing AF. The papers also compare different medications such as warfarin, rivaroxaban, and dabigatran for the treatment of AF.
Papers listed on taxonomy pages are the top few works per node from the OpenAlex snapshot. That list is not exhaustive and is not an endorsement. The topic map and the journal registry remain separate: there is still no authoritative topic-to-venue or topic-to-organization edge. Search is a lexical lookup, not a claim that a venue publishes a topic.
Most cited
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.
Most recent
- The Detection of Atrial Fibrillation by Implantable Event Recorders: A Study of Patients Who Have Had a Cryptogenic Stroke.
- Same-Day Discharge Versus Overnight Stay After Catheter Ablation: An Observational Matched-Cohort Study on Safety and Feasibility.
- Subclinical Atrial Fibrillation: Detection, Stroke Risk, and Treatment.
- Therapeutic duplication of anticoagulant therapy in an elderly patient: the role of the pharmacist in detecting medication-related problems
- Watching ‘AF’ter the Heart: the WATCHMAN TM device for atrial fibrillation
- Pharmacokinetic Variability of Direct Oral Anticoagulants and Calcium Channel Blockers: A Comparative Analysis of Exposure Data from Clinical Studies